Actively Recruiting
Metabolic Effects of a Diet Replaced With Essential Amino Acids
Led by Istituto Auxologico Italiano · Updated on 2026-03-31
60
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The effectiveness of low-protein diets supplemented with essential aminoacid (EAA) formulas in genetic disorders of amino acid (AA) catabolism, such as maple syrup urine disease (MSUD), is widely recognized (Blackburn PR et al. 2017). The main aim of the present study is to evaluate a difference in the effectiveness of a multidisciplinary rehabilitation program in patients with high degree of obesity with and without supplementation of this new formula of amino acids (essential + tricarboxylic acids - EAA-AC). For this reason, patients of both sexes, aged between 45 and 65, suffering from high-grade obesity will be recruited in Piancavallo. The enrolled patients divided, randomly, into two groups will be given: EAA-AC group a low-calorie and low-protein diet integrated with 4 sachets of EAA-AC supplement per day; the control group will follow a low-calorie and low-protein diet only with placebo. The parameters considered, after two weeks of treatment, will be: weight loss; the maintenance/recovery of muscle mass assessed through changes in body composition and functional tests (Hand grip, 6MWT or TUG) but also through the analysis of mitochondrial function in PBMC and circulating levels of mtDNA; the improvement of the glucose picture and the lipid profile. 1 month after discharge, patients will carry out an outpatient check-up to evaluate the maintenance of muscle mass using impedance testing.
CONDITIONS
Official Title
Metabolic Effects of a Diet Replaced With Essential Amino Acids
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Obesity (BMI >35kg/m2)
- Age 45 to 65 years
- Both sexes
- High-grade obesity
You will not qualify if you...
- Type 2 diabetes mellitus
- Renal failure
- Heart failure (New York Heart Association NYHA, class IV)
- Liver cirrhosis
- Neoplasms
- Muscular or non-autonomic pathologies
- Neurological-neurodegenerative pathologies
- Cognitive decline
- Non-menopausal women
- Bariatric surgery in the previous 12 months
- Pharmacological treatment for weight loss in the last three weeks
- Use of vitamin and amino acid supplements in the last three weeks
- Hormone therapy (e.g. L-thyroxine, testosterone)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Auxologico Italiano, Site Piancavallo
Oggebbio, Verbania, Italy, 28921
Actively Recruiting
Research Team
A
Amelia Brunani, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here